Plenary speakers

Charalambos Antoniades

Oxford, UK

Tuesday 01 June Future CVD management: from gene to phenotype to treatment

Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue?

Jan Borén

Gothenburg, Sweden

Monday 31 May Atherosclerosis: metabolism dysfunction drives inflammation in the vessels

Endothelial Mechanotransduction, Metabolism and Lipoprotein Transport in Atherosclerosis

Mark Daly

Helsinki, Finland

Tuesday 01 June Future CVD management: from gene to phenotype to treatment

From genetic discovery to clinical interventions to combat atherosclerosis

DeLisa Fairweather

Baltimore, USA

Wednesday 02 June The rise of cardiometabolic disease as global health threat: towards the UN 2030 goals

Gender and Cardiovascular Disease

Jean-Charles Fruchart

Lille/Basel, France

Tuesday 01 June Future CVD management: from gene to phenotype to treatment

SPPARM alpha agonist as for Nutrient and Energy Metabolism - Mechanisms and Therapeutic Opportunities

Thomas F. Lüscher

Zürich, Switzerland

Wednesday 02 June The rise of cardiometabolic disease as global health threat: towards the UN 2030 goals

AVSD management: will the future look smarter?

Esther Lutgens

Amsterdam, The Netherlands

Monday 31 May Atherosclerosis: metabolism dysfunction drives inflammation in the vessels

The Interface of Immune and Metabolic Responses in Atherosclerosis

Miguel Martinez-Gonzalez

Pamplona, Spain

Wednesday 02 June The rise of cardiometabolic disease as global health threat: towards the UN 2030 goals

The Mediterranean diet, its components, and cardiovascular disease

Gerard Pasterkamp

Utrecht, The Netherlands

Monday 31 May Atherosclerosis: metabolism dysfunction drives inflammation in the vessels

New Phenotypes for Stratification and Modeling of Atherosclerosis

Paolo Sassone-Corsi

Irvine, USA

Tuesday 01 June Future CVD management: from gene to phenotype to treatment

Does circardian rythm influence lipid metabolism and immune system?

Renu Virmani

Baltimore, USA

Monday 31 May Atherosclerosis: metabolism dysfunction drives inflammation in the vessels

Coronary Artery Calcification and its Progression: What Does it Really Mean?

Juleen Zierath

Stockholm, Sweden

Wednesday 02 June The rise of cardiometabolic disease as global health threat: towards the UN 2030 goals

Exercise, inactivity, and circadian rhythms - re-setting the clock in metabolic disease